Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol.
about
Efficacy and safety of low molecular weight heparin in patients with mechanical heart valves: systematic review and meta-analysis.Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.Perioperative anticoagulation in patients with mechanical heart valves undergoing elective surgery: results of a survey conducted among Korean physicians.The Perioperative Management of Antithrombotic Therapies Using Enoxaparin.Safety and cost-effectiveness of bridge therapies for invasive dental procedures in patients with mechanical heart valves.Results of surgery in general surgical patients receiving warfarin: retrospective analysis of 61 patients.Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Bridging therapy for oral anticoagulation increases the risk for bleeding-related complications in total joint arthroplasty.Outpatient-based primary and secondary thromboprophylaxis with low-molecular-weight heparin.Perioperative complications in patients on low-molecular-weight heparin bridging therapy.Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro study.2017 EACTS Guidelines on perioperative medication in adult cardiac surgery.“Bridging On the River Kwai”: The Perioperative Management of Anticoagulation Therapy
P2860
Q27690881-13EC833B-B9AD-43F7-96EE-D35DD2F52963Q33311569-CB922C36-C200-4C2C-BA4F-C117B4A12967Q33659307-06204173-13A0-40CD-A358-8EA4AA98BC85Q33661487-E0DBC27F-704C-4E34-9BBB-57449A43CC8EQ33822571-F9F125C0-8B78-4E84-B588-5DDA75CC069DQ35110661-EDED1EC5-2C19-4F58-ABBA-B11FAFDCFB74Q35752584-884BAC60-85AE-45E5-984F-2F457BEBDEADQ36068886-8C794DD2-9008-4BFD-924B-9A72A1B53FA7Q36951531-36AAF055-70C6-4F48-8C35-902EC2AD03DAQ38075615-51B91A44-CAAF-4313-B714-D38083316049Q44036210-2276400F-DE60-4448-A5D5-A860FCE80299Q47337039-78B196F5-174A-4011-B1BE-13D07110F044Q47365348-1F1E0ECF-976D-4509-8071-DDE42D35DC3BQ50065204-8B22EAE1-78DB-4F9E-ABEC-E8C772C55538Q57634229-E8830E46-2F5F-4418-A9DA-5D7EA6407790
P2860
Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Experience with enoxaparin in ...... ho must withhold acenocumarol.
@ast
Experience with enoxaparin in ...... ho must withhold acenocumarol.
@en
type
label
Experience with enoxaparin in ...... ho must withhold acenocumarol.
@ast
Experience with enoxaparin in ...... ho must withhold acenocumarol.
@en
prefLabel
Experience with enoxaparin in ...... ho must withhold acenocumarol.
@ast
Experience with enoxaparin in ...... ho must withhold acenocumarol.
@en
P2093
P2860
P356
P1433
P1476
Experience with enoxaparin in ...... ho must withhold acenocumarol.
@en
P2093
G Permanyer-Miralda
I Ferreira
J Soler-Soler
P2860
P304
P356
10.1136/HEART.89.5.527
P407
P577
2003-05-01T00:00:00Z